Humira

Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst
Fierce Pharma
Tue, 07/13/21 - 11:02 am
AbbVie
Humira
patents
biosimilars
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
AbbVie, building out its post-Humira future, posts 5 late-stage trial wins for Skyrizi and Rinvoq
Fierce Pharma
Wed, 05/26/21 - 12:05 pm
AbbVie
Humira
drug pricing
patents
immunology
Skyrizi
Rinvoq
clinical trials
Crohn's Disease
atopic dermatitis
AbbVie’s last stand: How an Icelandic billionaire’s biosimilar has one final shot to dethrone Humira
Endpoints
Mon, 05/24/21 - 11:30 pm
AbbVie
biosimilars
Humira
Alvotech
Humira patents take center stage as House panel targets AbbVie pricing
BioPharma Dive
Tue, 05/18/21 - 11:23 pm
AbbVie
Humira
drug pricing
Alvotech, not content to line up behind other Humira biosims, sues AbbVie over 'wrongful monopoly'
Fierce Pharma
Tue, 05/11/21 - 10:23 pm
AbbVie
patents
biosimilars
Humira
Alvotech
AbbVie's Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along
Fierce Pharma
Wed, 05/5/21 - 10:50 am
AbbVie
Humira
DTC advertising
television ads
Sanofi
Dupixent
Novo Nordisk
Rybelsus
This Is Why Humira Isn't AbbVie's Biggest Problem Right Now
Motley Fool
Mon, 05/3/21 - 10:55 am
AbbVie
Humira
patents
patent cliff
Imbruvica
AbbVie accuses rival of stealing blockbuster ‘trade secrets’ as clock ticks down on biosimilar assault
Endpoints
Wed, 03/24/21 - 10:23 am
AbbVie
Humira
trade secrets
Alvotech
13 leading drugmakers' top 3 drugs by revenue in 2020
Beckers Hospital Review
Wed, 03/24/21 - 10:18 am
drug sales
revenue
AbbVie
Humira
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
Endpoints
Tue, 03/16/21 - 11:04 am
AbbVie
Women's Health
Allergan
Humira
M&A
AbbVie's immunology newbies Skyrizi and Rinvoq pick up the slack from declining Humira, but safety questions dog execs
Fierce Pharma
Wed, 02/3/21 - 11:22 pm
AbbVie
FDA
Skyrizi
Rinvoq
Humira
earnings
Pharma TV ad spenders blow up December with spendiest month of 2020
Fierce Pharma
Wed, 01/6/21 - 10:50 am
television ads
AbbVie
Humira
Novo Nordisk
DTC ads
AbbVie eyes Humira matching move into psoriatic arthritis for immunology follow-up Skyrizi
Endpoints
Tue, 01/5/21 - 11:03 pm
AbbVie
Humira
psoriatic arthritis
Skyrizi
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
Endpoints
Wed, 12/9/20 - 10:39 am
AbbVie
Allergan
Humira
Rinvoq
How AbbVie Beat Expectations in Q3
Motley Fool
Sun, 11/1/20 - 01:49 pm
AbbVie
earnings
Humira
4 AbbVie brands land on pharma's top TV spenders list for September
Fierce Pharma
Sat, 10/17/20 - 11:46 pm
television ads
DTC ads
AbbVie
Humira
Skyrizi
Rinvoq
Ubrelvy
Oxford University to test AbbVie's Humira as COVID-19 treatment
Beckers Hospital Review
Fri, 10/2/20 - 01:03 pm
AbbVie
Humira
University of Oxford
clinical trials
COVID-19
AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman
Fierce Pharma
Tue, 09/1/20 - 12:28 pm
AbbVie
Imbruvica
Humira
drug pricing
patents
Pfizer's Unheralded Franchise That's Worth Billions of Dollars
Motley Fool
Sun, 08/16/20 - 10:44 pm
Pfizer
biosimilars
Humira
Inflectra
Remsima
Remicade
autoimmune disease
JNJ

Pages